Zichen Xu

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 17, 2026
Application of PARP1-Specific Pt(II)-Based Targeted Drug Conjugate in the Treatment of Ovarian Cancer by Inhibiting PARP1 and Suppressing DNA Damage Repair.

|Nov 13, 2024
Design, Synthesis, and Biological Evaluation of New Selective PDE4 Inhibitors for Topical Treatment of Psoriasis.

Dengqin He, Gang Li, Jia-Qiang Wu

|Dec 02, 2022
A Unique Chemo-photodynamic Antitumor Approach to Suppress Hypoxia via Ultrathin Graphitic Carbon Nitride Nanosheets Supported a Platinum(IV) Prodrug.

Zichen Xu, Yongzhi Yu, Jian Zhao

|Oct 18, 2021
A light-controlled multi-step drug release nanosystem targeting tumor hypoxia for synergistic cancer therapy.

Bin Zhang, Zichen Xu, Wen Zhou

|Mar 18, 2017
Novel hypoxia-targeting Pt(iv) prodrugs.

Zichen Xu, Jian Zhao, Shaohua Gou

Pageof 1

Frequent Collaborators

2 joint publications

Shaohua Gou

2 joint publications

Jian Zhao

2 joint publications

Shaohua Gou

1 joint publications

Zhixin Liao